|  | Normoalbuminuric type 2    diabetes (n=50)
 | Micro-albuminuric type 2 diabetes
 (n=50)
 | Control (n=50) | ANOVA | Tukey’s test | 
      
        | f | p | P1 | P2 | P3 | 
      
        | Fasting    blood glucse (mg/dl) | 214.5 ± 54.7 | 246.5    ± 65.8 | 78.1    ± 7.8 | 121.1 | <0.001* | 0.003* | <0.001* | <0.001* | 
      
        | 2-h    PP blood glucose  (mg/dl) | 280.1 ± 63.7 | 361.3 ± 54.2 | 95.1 ± 15.9 | 228.4 | <0.001* | <0.001* | <0.001* | <0.001* | 
      
        | HDL    (mg/dl) | 48.1 ± 8.9 | 39.6 ± 6.2 | 48.9 ± 5.1 | 23.5 | <0.001* | <0.001* | 0.6 | <0.001* | 
      
        | TAG    (mg/dl) | 116.5 ± 42.7 | 139.9 ± 36.8 | 96.7 ± 15.1 | 5.2 | 0.007 | 0.02* | 0.9 | 0.01* | 
      
        | TC    (mg/dl) | 230.4 ± 61.3 | 271.5 ± 51.6 | 171.8 ± 32.7 | 18.8 | <0.001* | 0.009* | 0.01* | <0.001* | 
      
        | LDL    (mg/dl) | 161.1 ± 63.7 | 204.5 ± 49.3 | 103.9 ± 28.7 | 21.1 | <0.001* | <0.001* | 0.26 | <0.001* | 
      
        | Fasting    insulin (μIU/ml) | 8.6 ± 5.6 | 13.3 ± 4.9 | 4.1 ± 1.5 | 21.6 | <0.001* | <0.001* | <0.001* | <0.001* | 
      
        | HOMA-IR | 4.7 ± 3.8 | 7.9 ± 4.5 | 1.1 ± 0.3 | 23.8 | <0.001* | 0.001* | <0.001* | <0.001* | 
      
        | Urinary    Albumin/Creatinine ratio (UACR , mg/g) | 16.9 ± 9.5 | 74.6     ± 33.1 | 18.1 ± 6.3 | 109.3 | <0.001* | <0.001* | 0.001* | <0.001* | 
      
        | Urea (mg    %) | 33.5 ± 9.1 | 73.4 ± 18.7 | 25.7 ± 6.8 | 135.3 | <0.001* | <0.001* | 0.22 | <0.001* | 
      
        | Serum    creatinine (mg/dl) | 0.79 ± 0.3 | 0.94 ± 0.7 | 0.7 ± 0.1 | 5.5 | 0.001* | <0.001* | 0.52 | <0.001* | 
      
        | estimated    GFR (eGFR ,ml/min per 1.73m2 ) | 95.6 ± 29.3 | 71.5 ± 25.3 | 94.4 ± 17.3 | 4.8 | 0.011* | 0.02* | 0.98 | 0.02* | 
      
        | sRAGE,    pg/mL | 3275 ± 270 | 4859 ± 317 | 1562  ± 386 | 748.7 | <0.001* | <0.001* | <0.001* | <0.001* | 
      
        | Pentosidinepg/mL | 273 ± 85 | 298 ±  26 | 257 ±  43 | 7.08 | 0.002* | 0.943 | 0.003* | 0.008* | 
      
        | AOPPs    (μmol/l) | 189 ± 5.1 | 203.1 ± 7.3 | 125.83 ± 4.05 | 1409.7 | <0.001* | <0.001* | <0.001* | <0.001* | 
      
        | Data    presented as means ± SD. P was calculated by one way ANOVA test followed by    Tukey’s post-hoc test. P was considered significant at <0.05.;    *Significant; P1 comparison between group I and II; P2 comparison between    group I and III; P3 comparison between group II and III. |